|
CH630257A5
(en)
*
|
1975-03-17 |
1982-06-15 |
Hoffmann La Roche |
Sustained release formulation
|
|
US4140755A
(en)
*
|
1976-02-13 |
1979-02-20 |
Hoffmann-La Roche Inc. |
Sustained release tablet formulations
|
|
US4167558A
(en)
*
|
1976-02-13 |
1979-09-11 |
Hoffmann-La Roche Inc. |
Novel sustained release tablet formulations
|
|
US4207890A
(en)
*
|
1977-01-04 |
1980-06-17 |
Mcneilab, Inc. |
Drug-dispensing device and method
|
|
JPS6024767B2
(ja)
*
|
1979-08-24 |
1985-06-14 |
塩野義製薬株式会社 |
腸溶性硬カプセル剤
|
|
DE3278491D1
(en)
*
|
1981-07-15 |
1988-06-23 |
Key Pharma |
Sustained release theophyline
|
|
US4451260A
(en)
*
|
1982-03-26 |
1984-05-29 |
Minnesota Mining And Manufacturing Company |
Sustained release oral medicinal delivery device
|
|
JPS5953410A
(ja)
*
|
1982-09-20 |
1984-03-28 |
Fujisawa Pharmaceut Co Ltd |
新型ソフトカプセル剤
|
|
JPS59193831A
(ja)
*
|
1983-04-18 |
1984-11-02 |
Sankyo Co Ltd |
腸溶性製剤の製造法
|
|
US4505890A
(en)
*
|
1983-06-30 |
1985-03-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation and method
|
|
SE457505B
(sv)
*
|
1984-01-10 |
1989-01-09 |
Lejus Medical Ab |
Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
|
|
DK62184D0
(da)
*
|
1984-02-10 |
1984-02-10 |
Benzon As Alfred |
Diffusionsovertrukket polydepotpraeparat
|
|
US4610870A
(en)
*
|
1984-10-05 |
1986-09-09 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
JPS61107782U
(xx)
*
|
1984-12-19 |
1986-07-08 |
|
|
|
US4735804A
(en)
*
|
1985-05-10 |
1988-04-05 |
Merck & Co., Inc. |
Drug delivery device which can be retained in the stomach for a controlled period of time
|
|
US4758436A
(en)
*
|
1985-05-29 |
1988-07-19 |
Merck & Co., Inc. |
Drug delivery device which can be retained in the stomach for a controlled period of time
|
|
US4767627A
(en)
*
|
1985-05-29 |
1988-08-30 |
Merck & Co., Inc. |
Drug delivery device which can be retained in the stomach for a controlled period of time
|
|
US4666705A
(en)
*
|
1985-06-03 |
1987-05-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4756911A
(en)
*
|
1986-04-16 |
1988-07-12 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4814178A
(en)
*
|
1987-07-01 |
1989-03-21 |
Sanford Bolton |
Floating sustained release therapeutic compositions
|
|
DE3803482A1
(de)
*
|
1988-02-05 |
1989-08-17 |
Lohmann Therapie Syst Lts |
Schwimmfaehiges orales therapeutisches system
|
|
JPH082781B2
(ja)
*
|
1988-10-18 |
1996-01-17 |
嘉明 川島 |
中空顆粒状医薬及びその製法
|
|
JPH05507717A
(ja)
*
|
1990-06-25 |
1993-11-04 |
ザ・デュポン・メルク・ファーマシュウティカル・カンパニー |
軟ゼラチンカプセル剤中で使用するための高められた溶解特性を有するアマンタジン塩酸塩懸濁液
|
|
US5232704A
(en)
*
|
1990-12-19 |
1993-08-03 |
G. D. Searle & Co. |
Sustained release, bilayer buoyant dosage form
|
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
|
US5314696A
(en)
*
|
1991-06-27 |
1994-05-24 |
Paulos Manley A |
Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
|
|
DE4406424A1
(de)
*
|
1994-02-28 |
1995-08-31 |
Bayer Ag |
Expandierbare Arzneiformen
|
|
JP2671257B2
(ja)
*
|
1995-07-13 |
1997-10-29 |
エーザイ株式会社 |
溶解遅延性ゼラチン製剤組成物
|
|
SE9702533D0
(sv)
|
1997-07-01 |
1997-07-01 |
Astra Ab |
New oral formulation
|
|
IN186245B
(xx)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
CN1203846C
(zh)
|
1998-03-19 |
2005-06-01 |
布里斯托尔-迈尔斯斯奎布公司 |
高溶解性药物的双相控释递送***和方法
|
|
EP1245227A1
(en)
*
|
2001-03-31 |
2002-10-02 |
Jagotec Ag |
A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
|
|
US20030203027A1
(en)
*
|
2002-04-26 |
2003-10-30 |
Ethicon, Inc. |
Coating technique for deposition of drug substance on a substrate
|
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
|
US7485322B2
(en)
*
|
2002-12-24 |
2009-02-03 |
Lek Pharmaceuticals D.D. |
Modified release pharmaceutical composition
|
|
ATE410152T1
(de)
*
|
2003-02-21 |
2008-10-15 |
Lek Pharmaceuticals |
Therapeutisches system mit amoxicillin und clavulansäure
|
|
MXPA06003769A
(es)
*
|
2003-11-04 |
2006-07-03 |
Shire Lab Inc |
Liberacion sostenida de moleculas farmacologicamente activas cargadas positivamente a partir de una matriz que contiene polimeros con atomos de oxigeno polarizados.
|
|
RU2420268C2
(ru)
*
|
2006-09-04 |
2011-06-10 |
Панацея Биотек Лимитед |
Способ программируемой плавучей доставки
|
|
WO2010020098A1
(zh)
*
|
2008-08-18 |
2010-02-25 |
北京天衡药物研究院 |
胃滞留药物释出***及其制备方法和用途
|
|
WO2009087665A2
(en)
*
|
2007-12-11 |
2009-07-16 |
Vishwanath Sudhir Nande |
Novel gastroretentive drug delivery system
|
|
GB2462022B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
|
|
FR2945945B1
(fr)
*
|
2009-05-29 |
2011-07-29 |
Flamel Tech Sa |
Procede de preparation de particules creuses et leurs applications
|
|
FR2945947B1
(fr)
|
2009-05-29 |
2011-07-29 |
Flamel Tech Sa |
Compositions pharmaceutiques flottantes a liberation controlee
|
|
JP5594484B2
(ja)
*
|
2009-07-06 |
2014-09-24 |
杏林製薬株式会社 |
中空構造を有する錠剤
|
|
US9314430B2
(en)
|
2010-07-05 |
2016-04-19 |
Jagotec Ag |
Floating gastric retentive dosage form
|
|
MX2014000517A
(es)
*
|
2011-07-14 |
2014-07-24 |
Apet Holding B V |
Composiciones de nicotinamida y el uso terapeutico de las mismas.
|
|
AU2012322323B2
(en)
|
2011-10-11 |
2016-04-21 |
Sun Pharmaceutical Industries Limited |
A gastroretentive dosage system and process of preparation thereof
|
|
EP2872140A1
(en)
*
|
2012-07-16 |
2015-05-20 |
APeT Holding B.V. |
Gastro-retentive drug delivery system
|
|
HUE025008T2
(en)
|
2012-10-12 |
2016-04-28 |
Omya Int Ag |
Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
|
|
US20170266112A1
(en)
|
2014-06-11 |
2017-09-21 |
Massachusetts Institute Of Technology |
Residence structures and related methods
|
|
BR112016028957B1
(pt)
|
2014-06-11 |
2021-12-14 |
The Brigham And Women's Hospital, Inc. |
Estrutura de residência gástrica
|
|
EP3034070A1
(en)
|
2014-12-18 |
2016-06-22 |
Omya International AG |
Method for the production of a pharmaceutical delivery system
|
|
EP3069713A1
(en)
|
2015-03-20 |
2016-09-21 |
Omya International AG |
Dispersible dosage form
|
|
CN104706613B
(zh)
*
|
2015-03-20 |
2018-01-16 |
华侨大学 |
一种胃漂浮空心缓释片的制备方法
|
|
CA2983272C
(en)
|
2015-05-01 |
2023-08-29 |
Massachusetts Institute Of Technology |
Triggerable shape memory induction devices
|
|
WO2017070612A1
(en)
|
2015-10-23 |
2017-04-27 |
Lyndra, Inc. |
Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
|
|
CN108697649A
(zh)
|
2015-12-08 |
2018-10-23 |
林德拉有限公司 |
用于胃驻留***的几何构型
|
|
CA3018011A1
(en)
*
|
2016-03-18 |
2017-09-21 |
Grunenthal Gmbh |
Floating pharmaceutical dosage form
|
|
EP3269361A1
(en)
|
2016-07-14 |
2018-01-17 |
Omya International AG |
Dosage form
|
|
CN110022861A
(zh)
|
2016-09-30 |
2019-07-16 |
林德拉有限公司 |
用于金刚烷类药物缓释的胃驻留***
|
|
WO2023166225A1
(en)
*
|
2022-03-04 |
2023-09-07 |
APET Holding B.V. |
Digestive enzyme formulations
|